Inserm Research Director
Tel.: +33 (0)6 07 79 56 49
(c) Monica Zilbovicius / Inserm
It is commonly admitted that the gaze plays an essential role in social interactions. At a very young age, human beings look others in the eye, because information from the eyes allows us to guess their intentions and feelings. In the brain, many studies highlight the importance of a specific region of the brain, the superior temporal sulcus (STS), in perception and behaviour of the gaze. However, to date, no experimental data has demonstrated a possible modification of the gaze by artificial modulation of a neural network.
Work conducted by Inserm Unit 1000, financed by AP-HP, has confirmed that ad hoc intervention in the STS was able to have an impact on the behaviour of the gaze. The researchers used transcranial magnetic stimulation (TMS): this method consists of applying a non-invasive and painless magnetic impulse to the brain through the skull, in order to study changes of gaze caused by inhibition of the STS by TMS, using oculometry (‘eye-tracking’). They showed 15 subjects films of actors and recorded the way they looked at these films before and after inhibition of the STS. In this way the researchers observed a significant distancing from the gaze of control subjects relative to the eyes of the actors, compared to the base measurement (cf. pictures). Inhibition of the superior temporal sulcus therefore selectively and transiently disrupts the movement of the subject’s gaze into the eyes of another subject.
These results offer new therapeutic prospects for autistic patients. In fact, many brain imaging studies have revealed the presence of anatomical and functional differences of the STS in this type of patient not displaying a marked preference of other people’s eyes.
 French Hospital clinical research programme (PHRC)
 Inserm Unit 1000, Paediatric Radiology Department, Necker Hospital for Sick Children, AP-HP
Treatments available for glioblastoma—malignant brain tumors—have little effect. An international collaboration led by the Laboratoire Neurosciences Paris-Seine (CNRS/ INSERM/UPMC) tested active ingredients from existing medications and eventually identified one compound of interest, prazosin, on these tumors. Not only did it seem to ...
The team led by Didier Leys and Régis Bordet (UMR-S 1171, Lille 2 University, Inserm, Lille University Hospital) has identified a biomarker that makes it possible to predict the risk of haemorrhagic complications from thrombolytic treatment following a Cerebrovascular Accident (CVA or ...
Tuning Eye-Gaze Perception by Transitory STS Inhibition
Ana Saitovitch1, Traian Popa3, Hervé Lemaitre1,2, Elza Rechtman1, Jean-Charles Lamy3, David Grévent1, Raphael Calmon1, Sabine Meunier3, Francis Brunelle1, Yves Samson4, Nathalie Boddaert1 and Monica Zilbovicius1
1INSERM U1000, Department of Paediatric Radiology, Necker Hospital for Sick Children, AP-HP, University René Descartes, PRES Sorbonne Paris Cité, UMR 1163, Institut Imagine, Paris, France
2Faculty of Medicine, Université Paris-Sud, Paris, France
3Inserm U1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ. Paris 06, UMR S 1127, Brain and Spinal Cord Institute, ICM, Research Neuro-Imaging Centre, CENIR, Paris, France
4Stroke Centre, Pitié-Salpêtrière Hospital Group, AP-HP, Université Pierre & Marie Curie, Paris, France
Cereb. Cortex first published online 5 March 2016
A molecule to regenerate insulin-producing cells in type 1 diabetic patients
Physical exercise to prevent the consequences of falls in older people
Drug abuse and depression: towards a new understanding of brain mechanisms
(Français) Un minimum d’effort pour un maximum d’effet